Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Ear needles may spark saliva in Dry-Mouth cancer survivors

NCT ID NCT04222478

Symptom relief Sponsor: Hopital Foch Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether auriculotherapy—a type of ear acupuncture using semi-permanent needles—can improve saliva production in people with dry mouth (xerostomia) after radiation for head and neck cancer. Participants receive three sessions of either real or sham auriculotherapy over three months. The main goal is to see if the real treatment increases saliva output compared to the sham, measured by the weight of compresses placed in the mouth.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
auriculotherapy (ear acupuncture with semi-permanent needles)
What this could lead to
If effective, this could offer a non-drug option to ease dry mouth after cancer treatment, improving comfort and quality of life.
What could go wrong
This is a small, early-stage trial with 65 participants. The sham group also receives needles, so the real benefit may be small or due to a placebo effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

65 people

The number who actually took part.

Started

Dec 2019

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients over 18 years old; * Complain about xerostomia after cervical irradiation in the context of ENT cancer; * End of radiotherapy\> 3 months * Covered by a national healthcare insurance * Consent form signed. Non inclusion Criteria: * Pregnant or breastfeeding women; * Local counterindication to auriculotherapy; * With anticoagulant treatment; * History or existing of hemophilia; * Valvular prosthesis; * Ear's pavilion infection; * Treatment by auriculotherapy or acupuncture in this indication in the previous 12 months; * Having started in the 48 hours preceding the first auriculotherapy session, any new management of xerostomia and likely to interfere with the study (specific medication and/or complementary therapeutic management); * Difficulty to comply with the treatment, questionnaires or study protocol; * Being deprived of liberty or under guardianship.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Xerostomia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Xerostomia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Xerostomia

Contacts and locations

Locations

  • Centre Hospitalier Régional Universitaire de Brest - Hôpital Morvan

    Brest, Brittany Region, 29600, France

  • GHP Saint Joseph

    Paris, 75014, France

  • Hôpital Foch

    Suresnes, 92150, France

  • Hôpital Forcilles

    Férolles-Attilly, 77150, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.